More than 110 of our companies have either completed an initial public
offering (IPO) or have been acquired by leading healthcare corporations.
Delphi's combination of experience, focus and commitment to funding healthcare ventures is unmatched. That's why the companies we fund and the limited partners that invest in us choose Delphi Ventures.
“I've been involved with many venture capital investors in my career, but none stands out like Delphi. Their approach is to stay informed, roll up their sleeves and pitch in to help solve problems.” Louis G. Lange, Chairman & CEO, CV Therapeutics, Inc.